-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Aerie Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2021.
- Aerie Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $3.64M, a 44.9% decline year-over-year.
- Aerie Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $18.4M, a 44.2% decline year-over-year.
- Aerie Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $29.5M, a 26.4% decline from 2020.
- Aerie Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2020 was $40.1M, a 11.1% decline from 2019.
- Aerie Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2019 was $45.1M, a 16.4% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)